Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

ClinicalTrials.gov ID: NCT00865969

Public ClinicalTrials.gov record NCT00865969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Trial of Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess efficacy and safety of belinostat in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL), who failed at least one prior systemic therapy.

Study identification

NCT ID
NCT00865969
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Spectrum Pharmaceuticals, Inc
Industry
Enrollment
129 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2008
Primary completion
Nov 4, 2013
Completion
Oct 26, 2014
Last update posted
Oct 28, 2021

2008 – 2014

United States locations

U.S. sites
42
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010
Wilshire Oncology Medical Group, Inc La Verne California 91750
Comprehensive Cancer Center Palm Springs California 92262
Yale Cancer Center-Section of Medical Oncology New Haven Connecticut 06520
Oncology Associates of Bridgeport Trumbull Connecticut 06611
Boca Raton Clinical Research Associates Boca Raton Florida 33432
Georgia Health Sciences University Augusta Georgia 30912-3125
Northwestern University Chicago Illinois 60611
Rush University Medical Center Chicago Illinois 60612
Kellogg Cancer Care Center Evanston Illinois 60201
Illinois Cancer Specialists/Cancer Care & Hematology Specialists of Chicagoland Niles Illinois 60714
Illinois CancerCare, P.C. Peoria Illinois 61615
Center for Cancers and Blood Disorders Bethesda Maryland 20817
Dana Farber Cancer Institute Boston Massachusetts 02115
Boston University Medical Center Boston Massachusetts 02118
Karmanos Cancer Institute Detroit Michigan 48201
Henry Ford Health System Detroit Michigan 48202
Saint Louis University St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Northern New Jersey Cancer Associates Hackensack New Jersey 07601
Morristown Memorial Hospital Morristown New Jersey 07962
Erie County Medical Center (Roswell Park) Buffalo New York 14215
Monter Cancer Center Lake Success New York 11067
New York University Cancer Institute New York New York 10016
New York University New York New York 10016
Memorial Sloan-Kettering Cancer Center New York New York 10021
Upstate Medical Univeristy Syracuse Syracuse New York 13210
Bronx River Medical Associates, PC The Bronx New York 10467
Duke University Medical Center Durham North Carolina 27710
Hematology Associates Bedford Ohio 44146
St Luke's Cancer Center Bethlehem Pennsylvania 18015
Penn State Hershey Cancer Institute Hershey Pennsylvania 17033
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Avera Cancer Center Sioux Falls South Dakota 57105
Associates In Oncology and Hematology Chattanooga Tennessee 37421
University of Tennessee Cancer Institute Knoxville Tennessee 37920
Accelerated Community Oncology Reseaerch Network, Inc. (ACORN) Memphis Tennessee 38138
UT - M. D. Anderson Cancer Center Houston Texas 77030
The UT Health Science Centre at San Antonio San Antonio Texas 78229
Massey Cancer Center Richmond Virginia 23298-0035
Cascade Cancer Center Kirkland Washington 98304
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00865969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00865969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →